PCRX · Pacira BioSciences, Inc. · Executive Compensation
$25.18
+0.13 (+0.52%)
At close · Oct 1
Return incl. dividend (before tax)
Market Cap
$1.00B
Shares
39.86M
Volume · Oct 1
236.58K
Avg daily vol (3M)
576.36K
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Frank Lee | Chief Executive Officer | $15,944,347 |
| Kristen Williams | Chief Administrative Officer and Secretary | $3,609,174 |
| Daryl Gaugler | Executive Vice President, Commercial Operations | $3,593,706 |
| Jonathan Slonin | Chief Medical Officer | $2,878,928 |
| Shawn M. Cross | Chief Financial Officer | $2,743,225 |
| Lauren Riker | Former Interim Chief Financial Officer | $1,438,907 |
| Charles A. Reinhart | Former Chief Financial Officer | $1,284,544 |
| David Stack | Former Chief Executive Officer | $727,378 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| David Stack | Former Chief Executive Officer | $6,878,091 |
| Kristen Williams | Chief Administrative Officer and Secretary | $1,600,861 |
| Jonathan Slonin | Chief Medical Officer | $1,593,213 |
| Daryl Gaugler | Executive Vice President, Commercial Operations | $1,533,627 |
| Charles A. Reinhart | Former Chief Financial Officer | $1,427,428 |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| David Stack | Former Chief Executive Officer | $6,851,340 |
| Daryl Gaugler | Executive Vice President, Commercial Operations | $2,291,396 |
| Kristen Williams | Chief Administrative Officer and Secretary | $2,008,835 |
| Jonathan Slonin | Chief Medical Officer | $1,879,034 |
| Charles A. Reinhart | Former Chief Financial Officer | $1,751,228 |
Fiscal 2019
| Executive | Role | Total |
|---|---|---|
| David Stack | Chief Executive Officer | $5,806,428 |
| Max Reinhardt | President | $4,575,038 |
| Kristen Williams | Chief Administrative Officer and Secretary | $1,692,717 |
| Roy Winston | Chief Clinical Officer | $1,611,800 |
| Charles A. Reinhart | Chief Financial Officer | $1,389,744 |
Fiscal 2018
| Executive | Role | Total |
|---|---|---|
| David Stack | Chief Executive Officer | $5,835,918 |
| Kristen Williams | Chief Administrative Officer and Secretary | $1,935,056 |
| Charles A. Reinhart | Chief Financial Officer | $1,407,673 |
Fiscal 2017
| Executive | Role | Total |
|---|---|---|
| David Stack | Chief Executive Officer | $4,718,917 |
| Kristen Williams | Chief Administrative Officer and Secretary | $1,527,724 |
| Charles A. Reinhart | Chief Financial Officer | $1,318,935 |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Dr. Samit Hirawat | Class III director | Appointed | 2026-01-28 |
| Alethia Young | Class II director | Appointed | 2025-06-13 |
| Frank D. Lee | Class II director | Appointed | 2025-06-13 |
| Marcelo Bigal | Class II director | Appointed | 2025-06-13 |
| Laura Brege | Chair of the Board | Appointed | 2025-01-30 |
| Andreas Wicki | member of the Board | Resigned | 2025-01-30 |
| Paul J. Hastings | Chair of the Board of Directors | Resigned | 2025-01-30 |
| Krys Corbett | Chief Business Officer | Appointed | 2025-01-21 |
| Brendan Teehan | Chief Commercial Officer | Appointed | 2025-01-21 |
| Brendan Teehan | Chief Commercial Officer | Appointed | 2025-01-21 |
| Shawn M. Cross | Chief Financial Officer | Appointed | 2024-10-21 |
| Lauren Riker | interim Chief Financial Officer | Appointed | 2024-09-27 |
| Gary Pace | Board of Directors | Retired | 2024-06-13 |
| David Stack | Chairman of the Board | Retired | 2023-12-21 |
| David Stack | Chief Executive Officer | Retired | 2023-12-21 |
| Paul Hastings | Chair of the Board | Appointed | 2023-12-21 |
| Frank D. Lee | member of the Board | Appointed | 2023-12-21 |
| Frank D. Lee | Chief Executive Officer | Appointed | 2023-12-21 |
| Frank Lee | member of the Board | Appointed | 2023-12-21 |
| David Stack | member of the Board | Retired | 2023-12-21 |
| Frank Lee | Chief Executive Officer | Appointed | 2023-12-21 |
| David Stack | Chief Executive Officer | Retired | 2023-12-21 |
| Michael Yang | Class I director | Appointed | 2023-10-10 |
| Abraham Ceesay | Class III director | Appointed | 2023-10-10 |
| Marcelo Bigal | Class II director | Appointed | 2023-10-10 |